News

Filter

Current filters:

GlobalImmunologicals

Global regenerative medicine market expected to reach $67 billion by 2020

Global regenerative medicine market expected to reach $67 billion by 2020

15-07-2014

The global regenerative medicine market will reach $67.6 billion by 2020, up from $16.4 billion in 2013…

BiotechnologyGlobalImmunologicalsMarkets & MarketingRegenerative medicineResearchStem cells

Abbott/Eisai's Humira has emerged as leading psoriasis agent

07-08-2012

For the treatment of psoriasis, Abbott/Eisai's Humira (adalimumab) has displaced Amgen/Stiefel/Pfizer/Takeda's…

Abbott LaboratoriesAmgenAnti-Arthritics/RheumaticsBiotechnologyEisaiEnbrelGlobalHumiraImmunologicalsJanssenMarkets & MarketingPfizerPharmaceuticalStelara Injection

Psoriasis drug market set to see strong growth until 2018, reaching a value of $6.7 million

28-09-2011

The psoriasis therapeutics market is forecast to show high growth until 2018 and market research firm…

DermatologicalsGlobalImmunologicalsMarkets & MarketingPharmaceutical

Balancing market value and patient populations - autoimmune treatments in emerging markets

21-05-2010

The large new patient pool in emerging markets indicates huge potential for the life sciences industry…

BiotechnologyGlobalImmunologicalsMarkets & MarketingPharmaceutical

Back to top